Company Filing History:
Years Active: 2022
Title: Innovations in Sleep Disorder Treatment by Bing-Huang Gau
Introduction
Bing-Huang Gau is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of sleep disorder treatment through his innovative research and patented inventions. His work focuses on improving sleep quality and addressing related health issues.
Latest Patents
Bing-Huang Gau holds a patent for the use of a novel strain known as ProGA28, which is deposited in the German Collection for Microorganisms and Cell Cultures (DSMZ) under the accession number DSM 33167 since May 28, 2019. This invention relates to the treatment and improvement of sleep disorders. The metabolites of ProGA28 have demonstrated the ability to enhance sleep quality, reduce the duration of rapid eye movement during sleep, decrease the time it takes to fall asleep, increase total sleep time, and improve the ratio of low waves during sleep. These benefits contribute to the treatment of sleep disorders and associated complications, such as anxiety and immune system diseases.
Career Highlights
Bing-Huang Gau is currently associated with Syngen Biotech, Co., Ltd., where he continues to advance his research in the field of sleep disorders. His innovative approach and dedication to improving health outcomes have positioned him as a key figure in this area of study.
Collaborations
Bing-Huang Gau has collaborated with notable colleagues, including Wei-Jen Chen and Po-An Chen. Their combined expertise contributes to the ongoing research and development of effective treatments for sleep disorders.
Conclusion
Bing-Huang Gau's innovative work in the treatment of sleep disorders through his patented invention of ProGA28 showcases his commitment to enhancing sleep quality and addressing related health issues. His contributions are significant in the field of sleep research and have the potential to improve the lives of many individuals suffering from sleep disorders.